Xaira Therapeutics

About Xaira Therapeutics

Xaira Therapeutics is a biotech startup applying AI to drug discovery and development, building generative models for protein and antibody design and foundation models for biology.

Xaira Therapeutics is pioneering the use of artificial intelligence to transform drug discovery and development. The company focuses on building predictive and agentic AI models across the entire drug discovery process, from target identification to patient stratification. Their technology includes generative AI for designing protein and antibody therapeutics and foundation models for understanding biology and disease. Xaira aims to increase the probability of success in drug development while reducing timelines and costs. The company is headquartered in South San Francisco, with offices in Seattle and London.